Incidence of Dry Eye Disease Lower With SGLT2 Inhibitors

(MedPage Today) -- A potential benefit of SGLT2 inhibitors in patients with type 2 diabetes (T2D) may be reduced incidence of dry eye disease, said authors of a large retrospective study. In more than 10,000 patients followed for approximately...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news